• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Expansion

Verlinvest builds up stake in Tony's Chocolonely

  • Wahida Ahmed
  • 10 February 2022
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Belgium-based private equity firm Verlinvest is to gain joint control of Tony's Chocolonely, a Dutch sustainable chocolate company, according to a competition authority filing.

The filing, dated 8 February, states that Verlinvest will share control of the confectioner with shell company A Genuine Chocolate Factory.

Financial terms of the deal were not disclosed.

Verlinvest, the investment fund of the De Spoelberch family, acquired a minority stake of around 26% in the business in February 2020, according to Het Financieele Dagblad. A press release at the time confirmed that the company struck an investment partnership with Verlinvest and London-based venture capital firm JamJar. At the time, it was reported that Tony's had hired Rabobank to help the company find an investment partner. Existing shareholders include Tony's employees and JamJar.

According to Het Financieele Dagblad, Verlinvest will hold the largest stake in Tony's following reports that the major shareholder of the company was selling part of its shares. The report was confirmed following the filing published by the ACM. The report noted that Henk Jan Beltman, director and major shareholder, said that following this deal his own shares will reduce from about 42% to around 26%; he did not disclose the financials of the transaction. The director told the Dutch media that, although Verlinvest is the largest shareholder, this does not mean the GP is in charge. According to Beltman, the GP must include him in big decisions and this was also the case when he was the largest shareholder of the business. The shares have been sold to pay off debts in Beltman's personal company.

In 2018, Beltman told the Dutch media that in order to accelerate growth he was in favour of selling the slave-free chocolate company to a multinational fast-moving consumer goods company like Nestlé or Mondelez.

Verlinvest is a privately owned family investment company that is backed by the Belgian family shareholders of the controlling group of AB-InBev. The firm was established in 1995 and has offices in New York, Brussels, London, Mumbai and Singapore. The GP has more than USD 3bn in assets under management.

According to a spokesperson for the GP, since its investment in Tony's in 2020, the GP has helped accelerate growth by introducing the brand to international markets allowing it to scale globally.

The GP invests in companies operating in the consumer goods and services, healthcare, industrials, technology and telecommunications sectors, according to Unquote Data. The GP is no stranger to investing in food businesses. In November 2016 it invested in Mutti, an Italy-based producer of tomato products; and in December 2016 it invested in Oatly, a Sweden-based producer of dairy alternatives.

Verlinvest declined to comment.

Company
Tony's was founded in 2006 by three Dutch journalists with a mission to free cocoa-based products from illegal child labour. The company retails 100% slave-free chocolate products. It has around 11-50 employees, according to Crunchbase.

Statista reported that in 2018/19 the company generated around EUR 53m (75%) of its revenues in the Netherlands, with significant sales in other countries as well. According to statistics published by Statista, the company had revenues of around EUR 6m in the US and had overall net revenue of around EUR 70m in 2018/19. Het Financieele Dagblad noted that over the course of 2019 the company's turnover increased by more than 25% to EUR 69.6m.

People
Tony's Chocolonely – Henk Han Beltmas (director).
Verlinvest – Ben Black (partner).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Expansion
  • Benelux
  • Consumer
  • Netherlands
  • Venture

More on Expansion

Risk and compliance management services
Inflexion reinvests in Apax-backed Alcumus

Inflexion originally sold the risk management business in February via a GBP 600m SBO to Apax

  • Expansion
  • 27 May 2022
Rafaele Tordjman of Jeito Capital
VC Profile: Jeito Capital in final stretch of biotech fund deployment

Founder Rafaèle Tordjman outlines the French sponsor’s strategy as it aims to remain independent amid wave of consolidation in healthcare funds

  • GPs
  • 13 May 2022
Doctor consultation via video link
Teachers' Venture Growth leads Alan's EUR 183m Series E

Temasek, Index, Coatue, Ribbit Capital, Exor, Dragoneer, and Lakestar also joined the round which values Alan at EUR 2.7bn

  • Expansion
  • 05 May 2022
Business loans for startups
Force Over Mass leads GBP 115m round for Outfund

UK revenue-based lender also supported by PostFinance, 1818 Venture Capital and Tribe Capital in the fundraise

  • Expansion
  • 28 April 2022

Latest News

IT consultants in the life sciences sector
  • Healthcare
FSN Capital acquires Epista Life Sciences

The GP said it will pursue a buy-and-build strategy in the life science IT services sector

  • 27 May 2022
New hires in the life sciences sector
  • People
Advent Life Sciences hires three partners

Dominic Schmidt is based in the UK, while Satish Jindal and Katrine Bosley join in the US

  • 27 May 2022
Pharmacies and drugs retailers
  • Exits
Five Arrows kicks off Laf Santé sale

Five Arrows has owned a majority stake in the France-based low-cost pharmacy chain since 2016

  • 27 May 2022
Healthcare software
  • Exits
Hg’s MEDIFOX sale launch draws large-cap sponsor interest

Hg acquired the software platform for care providers in 2018 from ECM Equity Capital Management

  • 27 May 2022
Back to Top

Most read

IT consultants in the life sciences sector
FSN Capital acquires Epista Life Sciences
New hires in the life sciences sector
Advent Life Sciences hires three partners
Pharmacies and drugs retailers
Five Arrows kicks off Laf Santé sale
Healthcare software
Hg’s MEDIFOX sale launch draws large-cap sponsor interest
David Gonzalvo of Gemba Private Equity
Gemba Private Equity heads for EUR 25m close for debut fund
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013